期刊文献+

脾边缘带淋巴瘤2例报道及文献复习 被引量:1

Splenic marginal zone lymphoma-two cases report and literature review
下载PDF
导出
摘要 目的:总结脾脏边缘带淋巴瘤的临床特点、病理特征、诊断、治疗方法及预后。方法:回顾我院2例脾边缘带淋巴瘤患者的临床资料,并复习相关文献。结果:2例患者均有脾大,经脾切除后病理明确诊断。化疗后均获得完全缓解,随访5年存活。结论:脾边缘带淋巴瘤是一种相对惰性的淋巴增殖性疾病,中位生存期长,约2/3患者诊断后生存期可超过8年,因此诊断后可采用相对保守的治疗措施。 Objective: To investigate the clinical and histological characteristics,diagnosis,treatment and prognosis of splenic marginal zone lymphoma. Methods: Two cases of splenic marginal zone lymphoma were analyzed retrospectively. And the related literatures were reviewed. Results: Both patients have splenomegaly,the diagnosis was made after splenectomy. After chemical therapy,two cases acquired complete remission,after 5 years follow-up,both patients were still alive. Conclusion: Splenic marginal zone lymphoma is a low-grade lymphoma with an indolent clinical course and a long median survival time. About two thirds patients can survive more than 8 years after diagnosis. So relatively conservative therapy is appreciated.
出处 《现代肿瘤医学》 CAS 2016年第4期623-625,共3页 Journal of Modern Oncology
关键词 脾边缘带淋巴瘤 脾切除 诊断 splenicmarginal zone lymphoma splenectomy diagnosis
  • 相关文献

参考文献9

  • 1Arcaini L, Lazzarino M, Colombo N, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use [ J ]. Blood, 2006, 107(12) :4643 -4649.
  • 2Kalpadakis C, Pangalis GA, Vassilakopoulos TP, et al. Treatment of splenic marginal zone lymphoma:should splenectomy be abandoned [ J ] ? Leuk Lymphoma,2013,18 ( 11 ): 6.
  • 3Montalban C, Abraira V, Arcaini L, et al. Simplification of risk stratification for splenic marginal zone lymphoma: a point - based score for practical use [ J ]. Leuk Lymphoma, 2013,7:29.
  • 4Thieblemont C, Felman P, Berger F, et al. Treatment of splenic mar- ginal zone B -cell lymphoma:an analysis of 81 patients [ J ]. Clin Lymphoma,2002,3 ( 1 ) :41 - 47.
  • 5Lenglet J, Traull6 C, Mounier N, et al. Long - term follow - up anal- ysis of 100 patients with splenic marginal zone lymphoma treatedwith splenectomy as first - line treatment [ J ]. Leuk Lymphoma, 2013,11:11.
  • 6Iannitto E, Ambrosetti A, Ammatuna E, et al. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients [ J ]. Cancer, 2004,101 ( 9 ) : 2050 - 2057.
  • 7Tsimberidou AM, Catovsky D, Schlette E, et al. Outcomes in pa- tients with splenic marginal zone lymphoma and marginal zone lym- phoma treated with ritnximab with or without chemotherapy or chemotherapy alone [ J ]. Cancer,2006,107 ( 1 ) : 125 - 135.
  • 8Kalpadakis C, Pangalis GA. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and com- parison with splenectomy [ J ]. Oncologist, 2013,18 ( 2 ) : 190 - 197.
  • 9Else M, Marin - Niebla A, de la Cruz F, et al. Rituximab, used a- lone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma [ J ]. Br J Haematol, 2012, 159 (3) :322 -328.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部